Comments
Loading...
Editas Medicine (EDIT) Forecast
NewsEarningsEditas Medicine (EDIT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Editas Medicine Stock Price, Quotes and Forecasts | NASDAQ:EDIT | Benzinga
Explore Editas Medicine stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EDIT.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Editas Medicine (EDIT) stock?
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Who are Editas Medicine (EDIT) competitors?
Other companies in Editas Medicine’s space includes: Kalaris Therapeutics (NASDAQ:KLRS), Quoin Pharmaceuticals (NASDAQ:QNRX), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR) and Genelux (NASDAQ:GNLX).
What is the forecast, or price target, for Editas Medicine (EDIT) stock?
Editas Medicine has a consensus price target of $9.44.
What is the current price for Editas Medicine (EDIT)?
The stock price for Editas Medicine (NASDAQ: EDIT) is $1.265 last updated April 16, 2025 at 12:37 PM EDT.
Does Editas Medicine (EDIT) pay a dividend?
There are no upcoming dividends for Editas Medicine.
When is Editas Medicine (NASDAQ:EDIT) reporting earnings?
Editas Medicine’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Editas Medicine (EDIT) going to split?
There is no upcoming split for Editas Medicine.
What sector and industry does Editas Medicine (EDIT) operate in?
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.